In this study using in vitro granuloma model, we observed that TNF-α blockade not only blocks its bioavailability, with significant modulation of granuloma, but also significantly reduces the levels of IL-12p40, IFN-γ, IL-17 and IL-10. The gene discussed is IL10; the disease is Granuloma.